STOCK TITAN

Equity grants to Illumina (ILMN) chief accounting officer detailed

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Illumina, Inc. reported new equity awards for VP and Chief Accounting Officer Scott D. Ericksen. On March 5, 2026, he acquired grants of performance share units and restricted stock units, all recorded as awards rather than open-market purchases.

The filing shows two grants of 1,609 performance share units each, with the ultimate shares to be issued ranging from 0% to 250% of these amounts based on Illumina’s three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026–2028 and on relative total shareholder return for the fiscal year ending December 31, 2028.

He also received 3,217 shares of common stock in the form of restricted stock units. These RSUs vest in four equal installments of 25% on February 15, 2027, February 15, 2028, February 15, 2029, and February 15, 2030, conditioned on his continued service.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ericksen Scott D

(Last) (First) (Middle)
5200 ILLUMINA WAY

(Street)
SAN DIEGO CA 92122

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ILLUMINA, INC. [ ILMN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/05/2026 A 3,217(1) A $128.24 16,446 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Shares (2) 03/05/2026 A 1,609 (2) 12/31/2028 Common Stock 1,609 $128.24 1,609 D
Performance Shares (3) 03/05/2026 A 1,609 (3) 12/31/2028 Common Stock 1,609 $128.24 1,609 D
Explanation of Responses:
1. Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 15, 2027, February 15, 2028, February 15, 2029, and February 15, 2030, subject to awardee's continuing status as a service provider on such dates.
2. Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028 with vesting on December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.
3. Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 31, 2028, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.
By: Robert Maynes for Scott D. Ericksen 03/09/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Illumina (ILMN) report for Scott D. Ericksen?

Illumina reported that Scott D. Ericksen received equity awards, not open-market trades. He was granted restricted stock units in common stock and two performance share unit awards, all classified as acquisitions under a grant or award transaction code A on March 5, 2026.

How many performance share units did Illumina grant to Scott D. Ericksen?

Scott D. Ericksen was granted two performance share unit awards of 1,609 units each. Each unit represents a contingent right to receive one share of Illumina common stock, with actual shares issued ranging from 0% to 250% of these amounts, depending on specified performance goals.

What performance metrics affect Illumina’s performance stock units in this Form 4?

The performance stock units depend on two metrics. One award is tied to three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026–2028, and another to relative total shareholder return for the fiscal year ending December 31, 2028, against pre-defined objectives.

When do Scott D. Ericksen’s Illumina restricted stock units vest?

The restricted stock units vest over four years. Twenty-five percent of the shares vest on each of February 15, 2027, February 15, 2028, February 15, 2029, and February 15, 2030, provided Ericksen continues as a service provider through each applicable vesting date.

Are the Illumina performance stock units guaranteed shares for Scott D. Ericksen?

The performance stock units are not guaranteed shares. Each unit is a contingent right to one share of common stock, with actual shares issued ranging from 0% to 250% of the granted amount, based on Illumina’s future earnings growth or relative total shareholder return performance.
Illumina Inc

NASDAQ:ILMN

View ILMN Stock Overview

ILMN Rankings

ILMN Latest News

ILMN Latest SEC Filings

ILMN Stock Data

19.05B
152.21M
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States
SAN DIEGO